Cartesian Therapeutics, Inc. (RNAC) Form 10-Q Quarterly Reports
Cartesian Therapeutics, Inc. (RNAC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RNAC
CIK: 1453687
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerWilliam Williamson
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-29 | 8-K | 0001453687-26-000105 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0000312069-26-000206 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001453687-26-000101 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001453687-26-000100 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-22 | — | SCHEDULE 13G/A Filing | 0000019617-26-000272 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-12 | 8-K | 0001453687-26-000090 | View SEC Doc Filr Page |
| 144 | 2026-06-09 | — | 144 Filing | 0001950047-26-005808 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-09 | 8-K | 0001140361-26-024556 | View SEC Doc Filr Page |
| 144 | 2026-06-02 | — | 144 Filing | 0001950047-26-005471 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-22 | 8-K | 0001453687-26-000087 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001134 | View SEC Doc Filr Page |
| S-8 | 2026-04-30 | — | S-8 | 0001453687-26-000084 | View SEC Doc Filr Page |
| 10-Q | 2026-04-30 | 2026-03-31 | 10-Q | 0001453687-26-000082 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | 8-K | 0001453687-26-000081 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-28 | 2025-12-31 | DEF 14A | 0001453687-26-000072 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | DEFA14A | 0001453687-26-000071 | View SEC Doc Filr Page |
| 4 | 2026-04-06 | 2026-04-02 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000149 | View SEC Doc Filr Page |
| 4 | 2026-04-06 | 2026-04-02 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000148 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-04-02 | — | SCHEDULE 13D/A Filing | 0001193125-26-140633 | View SEC Doc Filr Page |
| 8-K | 2026-03-30 | 2026-03-26 | 8-K | 0001453687-26-000068 | View SEC Doc Filr Page |
| 4 | 2026-03-13 | 2026-03-13 | FORM 4 | 0001453687-26-000066 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-03-13 | — | SCHEDULE 13G Filing | 0001642575-26-000003 | View SEC Doc Filr Page |
| 10-K | 2026-03-09 | 2025-12-31 | 10-K | 0001453687-26-000064 | View SEC Doc Filr Page |
| 8-K | 2026-03-09 | 2026-03-09 | 8-K | 0001453687-26-000063 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-05 | — | SCHEDULE 13G/A Filing | 0000315066-26-000393 | View SEC Doc Filr Page |